In the context of B-ALL, subgroups of patients with r-KMT2A, high hyperdiploidy, and r-ZNF384 subtypes exhibit higher FLT3 expression levels (5, 36, 37, 40, 42). This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.